SurfWax News Index  |  Track News  |  Save/Exchange Information |  About Us

    News and Articles on Aldurazyme



    FDA: Particles of Trash in Genzyme Drugs  Nov 14, 2009
    The drugs affected by the latest announcement include: Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen. All are manufactured at a biotech plant in Allston Landing, Mass. (CBS News)

    More contamination troubles for Genzyme  Nov 14, 2009
    In addition to Cerezyme and Fabrazyme, the drugs covered in the FDA s warning are Myozyme, which treats Pompe disease, a muscular disorder; Aldurazyme, which treats mucopolysaccharidosis, a metabolic disorder; and Thyrogen, which treats thyroid cancer ... Production of Aldurazyme, which formerly was made in Allston, was shifted to a Genzyme partner in California about 18 months ago. (Boston Globe)

    Bits of steel, rubber found in Genzyme drugs  Nov 14, 2009
    The drugs, which are used to treat rare enzyme disorders, include: Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen. advertisement. (MSNBC -- Health)

    Third-grader Jason Holtzclaw, 8, was family ‘hero’  Sep 18, 2009
    Fortunately, Jason got the actual drug, aldurazyme, not a placebo. It recharged Jason and gave him more moxie. (Atlanta Journal-Constitution -- Metro)

    BioMarin: Genzyme virus problem wont hurt its drug  Jun 19, 2009
    said a virus at s Boston-area bulk manufacturing plant, which last made BioMarin s drug Aldurazyme in September, won t have an impact on the supply of its drug or the Novato company s revenue ... Aldurazyme a treatment for MPS I, a rare and fatal disease caused by an enzyme deficiency was last filled at the Genzyme facility in September 2008, according to BioMarin (NASDAQ: BMRN) ... BioMarin makes the bulk material used in Aldurazyme at its Novato facility. (San Francisco Business Times, CA)

    Genzyme Shuts Down Facility After Detecting Virus  Jun 17, 2009
    said the contamination will not impact production of Aldurazyme, which treats an enzyme disorder and is marketed by Genzyme. Analysts throughout Wall Street expect the supply constraints of Fabrazyme and Cerezyme to cut into the company's revenue during the quarter, with some estimates shaving as much as $300 million in sales. (ABC News -- Wire)

    Myozyme sales boost Genzyme profit  Feb 12, 2009
    The drugs are some of the world's costliest and include Cerezyme for Gaucher disease and Aldurazyme for a condition called MPS1. Both cost about $200,000 a year. (Boston Globe)




    Back to Drugs News

[ Terms Of Use | Privacy | About ]
©1998-2009 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2009